PDCD1 and triple-negative breast carcinoma: Lastly, to ensure the standard use of the chicken embryo model for PD-1 inhibitor studies, pembrolizumab was also tested on another MDA-MB-231 triple-negative breast cancer model, as well as another anti-human PD-1, nivolumab (OPDIVO®).